Europe — EMA

Orap (Pimozide)

Pimozide, the active ingredient in Orap, is a antipsychotic presented as a tablet for oral use. It is used to treat chronic tic disorders, particularly in adolescents and adults.

Pimozide

Request sourcing

Pack/s

What is Pimozide?

Pimozide, the active ingredient in Orap, is a antipsychotic presented as a tablet for oral use. It is used to treat chronic tic disorders, particularly in adolescents and adults.

GNH USA supplies Orap as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Pimozide used for?

Orap acts on the dopamine pathway and is indicated for several clinical conditions.

- Chronic tics and Tourette syndrome : Red - Schizoph … etc….

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →